{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:39:14Z","timestamp":1793176754015,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clcc.2026.01.006","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T16:53:05Z","timestamp":1769705585000},"page":"181-190.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Circulating Tumor DNA as a Biomarker for Recurrence After Curative Resection of Colorectal Cancer Liver Metastases: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6016-9221","authenticated-orcid":false,"given":"Atta Ullah","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Ahad","family":"Mehboob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asraa Abdulsahib","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awais","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Jawad","family":"Kadham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2026.01.006_bib0001","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12885-017-3925-x","article-title":"Colorectal cancer liver metastases - a population-based study on incidence, management and survival","volume":"18","author":"Engstrand","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2026.01.006_bib0002","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","article-title":"Epidemiology and management of liver metastases from colorectal cancer","volume":"244","author":"Manfredi","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2026.01.006_bib0003","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1200\/JCO.2007.11.0833","article-title":"Actual 10-year survival after resection of colorectal liver metastases defines cure","volume":"25","author":"Tomlinson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2026.01.006_bib0004","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0b013e3181b4539b","article-title":"Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients","volume":"250","author":"De Jong","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2026.01.006_bib0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2026.01.006_bib0006","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/SLA.0b013e31815aa2c2","article-title":"Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients","volume":"247","author":"Rees","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2026.01.006_bib0007","unstructured":"Nordlinger, B; Guiguet, M; Vaillant, J-C; et al. Surgical resection of colorectal carcinoma metastases to the liver a prognostic scoring system to improve case selection, based on 1568 patients. Cancer. doi:10.1002\/(SICI)1097-0142(19960401)77:7."},{"key":"10.1016\/j.clcc.2026.01.006_bib0008","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1072-7515(99)00089-7","article-title":"Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system","volume":"189","author":"Iwatsuki","year":"1999","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.clcc.2026.01.006_bib0009","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1470-2045(14)70105-6","article-title":"Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the new EPOC randomised controlled trial","volume":"15","author":"Primrose","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2026.01.006_bib0010","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2026.01.006_bib0011","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41416-022-02017-9","article-title":"The utility of CtDNA in detecting minimal residual disease following curative surgery in colorectal cancer: a systematic review and meta-analysis","volume":"128","author":"Faulkner","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2026.01.006_bib0012","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.clcc.2026.01.006_bib0013","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","article-title":"Current and future perspectives of liquid biopsies in genomics-driven oncology","volume":"20","author":"Heitzer","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.clcc.2026.01.006_bib0014","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41571-019-0187-3","article-title":"Liquid biopsy and minimal residual disease - latest advances and implications for cure","volume":"16","author":"Pantel","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clcc.2026.01.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.clcc.2026.01.006_bib0016","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2026.01.006_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023418","article-title":"High fragmentation characterizes tumour-derived circulating DNA","volume":"6","author":"Mouliere","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clcc.2026.01.006_bib0018","first-page":"1659","article-title":"DNA Fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells1","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.clcc.2026.01.006_bib0019","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.clcc.2026.01.006_bib0020","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6219","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"Tie","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.clcc.2026.01.006_bib0021","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jamaoncol.2019.0512","article-title":"Prognostic potential of circulating tumor DNA measurement in postoperative surveillance of nonmetastatic colorectal cancer","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2026.01.006_bib0022","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jamaoncol.2019.3616","article-title":"Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer","volume":"5","author":"Tie","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2026.01.006_bib0023","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-021-01089-z","article-title":"Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer","volume":"14","author":"Chen","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clcc.2026.01.006_bib0024","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/ijc.33312","article-title":"Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: individual patient pooled analysis of three cohort studies","volume":"148","author":"Tie","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2026.01.006_bib0025","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaoncol.2019.0528","article-title":"Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer","volume":"5","author":"Reinert","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2026.01.006_bib0026","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","article-title":"Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer","volume":"386","author":"Tie","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clcc.2026.01.006_bib0027","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3390\/cells12212520","article-title":"Circulating tumour DNA as biomarker for colorectal liver metastases: a systematic review and meta-analysis","volume":"12","author":"Wullaert","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.clcc.2026.01.006_bib0028","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221133171","article-title":"Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis","volume":"14","author":"Callesen","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.clcc.2026.01.006_bib0029","first-page":"372","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clcc.2026.01.006_bib0030","unstructured":"Wells, G; Shea, B; O\u2019Connell, D; Peterson, J; Welch, V; Losos, M; Tugwell, P Newcastle-Ottawa Scale (NOS) | Ottawa Hospital Research Institute Available at: https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale Accessed: January 02, 2026."},{"key":"10.1016\/j.clcc.2026.01.006_bib0031","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1245\/s10434-023-13362-1","article-title":"Recurrence prediction by circulating tumor DNA in the patient with colorectal liver metastases after hepatectomy: a prospective biomarker study","volume":"30","author":"Liu","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2026.01.006_bib0032","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejca.2021.12.026","article-title":"Tumour-agnostic circulating tumour DNA analysis for improved recurrence surveillance after resection of colorectal liver metastases: a prospective cohort study","volume":"163","author":"\u00d8gaard","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2026.01.006_bib0033","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1097\/JS9.0000000000001236","article-title":"Personalized circulating tumor DNA monitoring improves recurrence surveillance and management after curative resection of colorectal liver metastases: a prospective cohort study","volume":"110","author":"Li","year":"2024","journal-title":"Int J Sur"},{"key":"10.1016\/j.clcc.2026.01.006_bib0034","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1097\/JS9.0000000000002504","article-title":"Dynamic CtDNA monitoring in adjuvant therapy and recurrence for colorectal liver metastases (PKUCRLM-01): a prospective study","volume":"C1","author":"Xu","year":"2025","journal-title":"Int J Sur"},{"key":"10.1016\/j.clcc.2026.01.006_bib0035","first-page":"70","article-title":"Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases","author":"Bolhuis","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clcc.2026.01.006_bib0036","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/XCS.0000000000000093","article-title":"Effect of Co-mutation of RAS and TP53 on postoperative CtDNA detection and early recurrence after hepatectomy for colorectal liver metastases","volume":"234","author":"Nishioka","year":"2022","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.clcc.2026.01.006_bib0037","first-page":"87","article-title":"Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study","author":"Wullaert","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.clcc.2026.01.006_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003620","article-title":"Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: a prospective cohort study","volume":"18","author":"Tie","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.clcc.2026.01.006_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1418696","article-title":"Feasibility of CtDNA in detecting minimal residual disease and predicting recurrence for colorectal cancer liver metastases","volume":"14","author":"Kalil","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.clcc.2026.01.006_bib0040","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/SLA.0000000000005461","article-title":"Prospective study of perioperative circulating tumor DNA dynamics in patients undergoing hepatectomy for colorectal liver metastases","volume":"277","author":"Newhook","year":"2023","journal-title":"Ann Surg"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153300282600006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153300282600006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:25:34Z","timestamp":1793175934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153300282600006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S153300282600006X"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2026.01.006","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating Tumor DNA as a Biomarker for Recurrence After Curative Resection of Colorectal Cancer Liver Metastases: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2026.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}